Mid-Day Commentary & Reports For: (OTCQB: CTIX), (OTCQB; GRPH)
Cellceutix Corp. (OTCQB: CTIX), a development stage biopharmaceutical company engaged in the discovery and development of small molecule drugs to treat diseases mainly in the areas of cancer and inflammatory disease, is up sharply in mid-day trading today, extending its gains from the previous trading session.
View full press release